JP2020517727A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517727A5 JP2020517727A5 JP2019558668A JP2019558668A JP2020517727A5 JP 2020517727 A5 JP2020517727 A5 JP 2020517727A5 JP 2019558668 A JP2019558668 A JP 2019558668A JP 2019558668 A JP2019558668 A JP 2019558668A JP 2020517727 A5 JP2020517727 A5 JP 2020517727A5
- Authority
- JP
- Japan
- Prior art keywords
- preparation according
- cannabidiol
- concentration
- vehicle
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022089421A JP2022130390A (ja) | 2017-04-27 | 2022-06-01 | 安定なカンナビノイド製剤 |
| JP2024113145A JP2024161363A (ja) | 2017-04-27 | 2024-07-16 | 安定なカンナビノイド製剤 |
| JP2025077148A JP2025118786A (ja) | 2017-04-27 | 2025-05-07 | 安定なカンナビノイド製剤 |
| JP2025077149A JP2025118787A (ja) | 2017-04-27 | 2025-05-07 | 安定なカンナビノイド製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/499,178 | 2017-04-27 | ||
| US15/499,178 US12544389B2 (en) | 2014-05-29 | 2017-04-27 | Stable cannabinoid formulations |
| PCT/US2017/052897 WO2018200024A1 (en) | 2017-04-27 | 2017-09-22 | Stable cannabinoid formulations |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022089421A Division JP2022130390A (ja) | 2017-04-27 | 2022-06-01 | 安定なカンナビノイド製剤 |
| JP2024113145A Division JP2024161363A (ja) | 2017-04-27 | 2024-07-16 | 安定なカンナビノイド製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020517727A JP2020517727A (ja) | 2020-06-18 |
| JP2020517727A5 true JP2020517727A5 (cg-RX-API-DMAC7.html) | 2020-11-12 |
Family
ID=63920361
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019558668A Pending JP2020517727A (ja) | 2017-04-27 | 2017-09-22 | 安定なカンナビノイド製剤 |
| JP2022089421A Pending JP2022130390A (ja) | 2017-04-27 | 2022-06-01 | 安定なカンナビノイド製剤 |
| JP2024113145A Pending JP2024161363A (ja) | 2017-04-27 | 2024-07-16 | 安定なカンナビノイド製剤 |
| JP2025077149A Pending JP2025118787A (ja) | 2017-04-27 | 2025-05-07 | 安定なカンナビノイド製剤 |
| JP2025077148A Pending JP2025118786A (ja) | 2017-04-27 | 2025-05-07 | 安定なカンナビノイド製剤 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022089421A Pending JP2022130390A (ja) | 2017-04-27 | 2022-06-01 | 安定なカンナビノイド製剤 |
| JP2024113145A Pending JP2024161363A (ja) | 2017-04-27 | 2024-07-16 | 安定なカンナビノイド製剤 |
| JP2025077149A Pending JP2025118787A (ja) | 2017-04-27 | 2025-05-07 | 安定なカンナビノイド製剤 |
| JP2025077148A Pending JP2025118786A (ja) | 2017-04-27 | 2025-05-07 | 安定なカンナビノイド製剤 |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP3615079B1 (cg-RX-API-DMAC7.html) |
| JP (5) | JP2020517727A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3062814C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018200024A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12544389B2 (en) | 2014-05-29 | 2026-02-10 | Fresh Cut Development, Llc | Stable cannabinoid formulations |
| GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2539472A (en) | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| JP2020517727A (ja) * | 2017-04-27 | 2020-06-18 | インシス・ディベロップメント・カンパニー・インコーポレイテッド | 安定なカンナビノイド製剤 |
| GB2568929A (en) | 2017-12-01 | 2019-06-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| WO2020123407A1 (en) | 2018-12-11 | 2020-06-18 | Disruption Labs Inc. | Compositions for the delivery of therapeutic agents and methods of use and making thereof |
| GB2584140A (en) * | 2019-05-23 | 2020-11-25 | Gw Res Ltd | Use of cannabidiol in the treatment of epileptic spasms |
| US20220347118A1 (en) * | 2019-09-09 | 2022-11-03 | Cardiol Therapeutics Inc. | Stable medicinal cannabidiol compositions |
| GB2588461A (en) * | 2019-10-25 | 2021-04-28 | Gw Res Ltd | Use of cannabidiol preparations in the treatment of absence epilepsy |
| US12642806B2 (en) * | 2019-10-25 | 2026-06-02 | Cardiol Therapeutics Inc. | Cannabidiol compositions for use in treating heart conditions |
| GB202009321D0 (en) | 2020-06-18 | 2020-08-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| AU2021347760B2 (en) * | 2020-09-24 | 2024-07-25 | Nicoventures Trading Limited | Formulation |
| TW202231192A (zh) * | 2020-09-24 | 2022-08-16 | 英商尼可創業貿易有限公司 | 包裝調配物 |
| JP2024528569A (ja) * | 2021-07-13 | 2024-07-30 | イーピーエム（アイピー）， インコーポレイテッド | プラダー・ウィリー症候群を治療するためのカンナビジオール酸エステル |
| CN117813081A (zh) * | 2021-07-13 | 2024-04-02 | Epm(Ip)公司 | 用于治疗普拉德-威利综合征的大麻二醇酸酯 |
| EP4376820A1 (en) * | 2021-07-28 | 2024-06-05 | GW Research Limited | Use of cannabidiol in the treatment of epilepsy |
| AU2023361756A1 (en) * | 2022-10-12 | 2025-05-22 | Leiutis Pharmaceuticals Llp | Novel liquid oral formulations of cannabidiol |
| CN116444351A (zh) * | 2022-11-18 | 2023-07-18 | 中国人民解放军军事科学院军事医学研究院 | 一种核辐射损伤中对小肠有保护作用的天然小分子化合物 |
| CN116172988A (zh) * | 2022-11-18 | 2023-05-30 | 中国人民解放军军事科学院军事医学研究院 | 大麻二酚用于制备急性放射病的药物的用途 |
| CN115887426A (zh) * | 2022-11-18 | 2023-04-04 | 中国人民解放军军事科学院军事医学研究院 | 大麻二酚在制备核辐射损伤后骨髓恢复药物中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0514060A (pt) * | 2004-08-03 | 2008-05-27 | Orexigen Therapeutics Inc | combinação de bupropion e um segundo composto para acarretar a perda de peso |
| NZ568400A (en) * | 2005-11-23 | 2011-11-25 | Ironwood Pharmaceuticals Inc | Methods and compositions for the treatment of gastrointestinal disorders |
| GB2438682A (en) * | 2006-06-01 | 2007-12-05 | Gw Pharma Ltd | New use for cannabinoids |
| US20110262442A1 (en) * | 2009-11-06 | 2011-10-27 | Adenios, Inc. | Compositions for treating cns disorders |
| US20130210821A1 (en) * | 2010-05-27 | 2013-08-15 | James E. Vath | Methods for Treating Obesity |
| US20160271252A1 (en) * | 2014-05-29 | 2016-09-22 | Insys Development Company, Inc. | Stable cannabinoid formulations |
| US20160367496A1 (en) * | 2014-05-29 | 2016-12-22 | Insys Development Company, Inc. | Stable cannabinoid formulations |
| CA2950424C (en) * | 2014-05-29 | 2023-03-14 | Insys Pharma, Inc. | Stable cannabinoid formulations |
| US11331279B2 (en) | 2014-05-29 | 2022-05-17 | Radius Pharmaceuticals, Inc. | Stable cannabinoid formulations |
| DK3302437T4 (da) * | 2015-05-28 | 2026-02-23 | Fresh Cut Dev Llc | Stabile cannabinoidformuleringer |
| JP2020517727A (ja) * | 2017-04-27 | 2020-06-18 | インシス・ディベロップメント・カンパニー・インコーポレイテッド | 安定なカンナビノイド製剤 |
-
2017
- 2017-09-22 JP JP2019558668A patent/JP2020517727A/ja active Pending
- 2017-09-22 EP EP17907335.8A patent/EP3615079B1/en active Active
- 2017-09-22 WO PCT/US2017/052897 patent/WO2018200024A1/en not_active Ceased
- 2017-09-22 CA CA3062814A patent/CA3062814C/en active Active
- 2017-09-22 EP EP25152261.1A patent/EP4516355A3/en active Pending
-
2022
- 2022-06-01 JP JP2022089421A patent/JP2022130390A/ja active Pending
-
2024
- 2024-07-16 JP JP2024113145A patent/JP2024161363A/ja active Pending
-
2025
- 2025-05-07 JP JP2025077149A patent/JP2025118787A/ja active Pending
- 2025-05-07 JP JP2025077148A patent/JP2025118786A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7374951B2 (ja) | 安定なカンナビノイド製剤 | |
| JP2019048843A5 (cg-RX-API-DMAC7.html) | ||
| RU2017126039A (ru) | САМОЭМУЛЬГИРУЮЩАЯСЯ КОМПОЗИЦИЯ ω3 ЖИРНОЙ КИСЛОТЫ | |
| JP2018521042A5 (cg-RX-API-DMAC7.html) | ||
| JP2013511496A5 (cg-RX-API-DMAC7.html) | ||
| JP2013521310A5 (cg-RX-API-DMAC7.html) | ||
| BG108071A (bg) | Есенциални мастни n-3-киселини в лечението на сърдечна недостатъчност и сърдечна слабост | |
| JP2014528474A5 (cg-RX-API-DMAC7.html) | ||
| JP6462045B2 (ja) | スルフォラファンの単離及び精製 | |
| JP2016515530A5 (cg-RX-API-DMAC7.html) | ||
| JP2015530382A5 (cg-RX-API-DMAC7.html) | ||
| JP2014515407A5 (cg-RX-API-DMAC7.html) | ||
| JP6605047B2 (ja) | 疼痛治療のためのセレコキシブの経口用組成物 | |
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2012533565A5 (cg-RX-API-DMAC7.html) | ||
| JP2015509909A5 (cg-RX-API-DMAC7.html) | ||
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| JP2015522015A5 (cg-RX-API-DMAC7.html) | ||
| WO2015155544A1 (en) | Delivery of non-steroidal antiinflammatory agents to the brain via the nasal tract to treat neurological disorders | |
| CN103338761A (zh) | 抗癌剂所引起的周围神经病的预防或治疗剂 | |
| JP2016512247A5 (cg-RX-API-DMAC7.html) | ||
| EP2552199A1 (en) | Improved stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone | |
| RU2016103098A (ru) | Способ предотвращения и/или лечения хронической травматической энцефалопатии - ii | |
| RU2018143564A (ru) | Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа | |
| RU2018130097A (ru) | Лечение экземы кистей |